While China represents a number of advantages and a strong environment for clinical research, including vast patient populations and fast patient recruitment, there are still a number of obstacles that present significant challenges to pharmaceutical...
The rapidly accelerating transition from traditional drug discovery
and development to personalized medicine is pushing researchers to
understand more about their samples and to deploy them in novel ways.
High-quality research samples with ...
The new paradigm rapidly emerging in comprehensive sample management is being driven by a powerful and unprecedented combination of scientific, economic and regulatory factors. Continuing advances in biomarker research mandate the more efficient use ...